Goldman Sachs asks in biotech research report: ‘Is curing patients a sustainable business model?’

Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'

Goldman Sachs warns sales from the most successful disease treatments are difficult to maintain.